Product logins

Find logins to all Clarivate products below.


Minimally Invasive Vertebral Compression Fracture Treatments | Medtech 360 | Market Analysis | Global | 2016

The global MIVCF treatment device market will be driven by newly approved indications, new product launches, and increasing adoption of advanced premium-priced technologies. As a result, the market will see improving growth through 2024 despite ongoing obstacles, such as changes to treatment recommendations, challenging reimbursement environments, and negative publicity surrounding significant products.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for MIVCFtreatment devices in the global region across a 10-year period.

Related Medtech Insights Reports

Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI,…
Report
Minimally Invasive Vertebral Compression Fracture Treatments – Market Insights – Global
Despite the negative impact of COVID-19, the global MIVCF treatment market is expected to show modest growth through 2033, driven by moderate growth in the Asia Pacific region and sustained…
Report
Biosurgical Agents | Medtech 360 | Market Insights | US | 2024
The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…
Report
Diagnostic Imaging Systems – Market Insights – Japan
The diagnostic imaging system market in Japan will see slow growth through 2032. Manufacturers in this space are actively introducing technologically advanced products equipped with digital and AI…
Report
Minimally Invasive Vertebral Compression Fracture Treatments | Market Insights | Global | 2023
Despite the short-term negative impact of the COVID-19 pandemic, the global market for MIVCF treatments will show particularly strong growth through 2031, reflecting the moderate growth in the…